We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




NIH Extends Collaboration for HIV Diagnostics

By HospiMedica staff writers
Posted on 09 Apr 2007
Human immunosuppressive virus (HIV) diagnostics are important to maintaining the safety of the blood supply through donor screening and by providing early diagnosis and monitoring of HIV infection so that patients may benefit from early treatment regimens.

The U.S. More...
National Institutes of Health (NIH; Bethesda, MD, USA), an agency of the U.S. Department of Health and Human Services, and Institut Pasteur (IP; Paris, France), a private non-profit foundation, announced an agreement to extend their long-standing collaboration in health research and the management of inventions arising from this research. These two institutions have been leaders and collaborators in the field of HIV/AIDS research for more than 20 years. The extended agreement will initially facilitate the patenting and licensing of a large portfolio of intellectual property held by NIH and IP in the field of HIV-1 diagnostics. Additional long-term public health benefits are expected as the agreement provides a new framework for further support and encouragement of collaborative research in a variety of areas by leading scientists at both the NIH and IP.

To date, effective HIV-1 diagnostic test kits based upon technology licensed from IP and NIH has been distributed worldwide by many companies, saving millions of lives. As the science of understanding the HIV-1 virus has progressed, new technologies arising from the laboratories of IP and NIH and subsequently developed by diagnostics companies now allow these tests to be provided with increased sensitivity and specificity but at a lower cost.

According to the latest figures published an estimated 39.5 million people are living with HIV. There were 4.3 million new infections in 2006 with 2.8 million (65%) of these occurring in sub-Saharan Africa and important increases in Eastern Europe and Central Asia, where there are some indications that infection rates have risen by more than 50% since 2004. In 2006, 2.9 million people died of AIDS-related illnesses.

Institut Pasteur is dedicated to the prevention and treatment of diseases through research, education, and public health activities. A large part of Institut Pasteur's research activities is devoted to infectious diseases with important efforts on AIDS research.


Related Links:
U.S. National Institutes of Health
Institut Pasteur

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Infrared Digital Thermometer
R1B1
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.